4.4 Article

Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial

Nina Kimer et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Review article: the antimicrobial effects of rifaximin on the gut microbiota

H. L. DuPont

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Review Substance Abuse

Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk

Phillipp Hartmann et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2015)

Review Gastroenterology & Hepatology

Gut-Liver Axis in Alcoholic Liver Disease

Gyongyi Szabo

GASTROENTEROLOGY (2015)

Review Gastroenterology & Hepatology

Trends in the management and burden of alcoholic liver disease

Philippe Mathurin et al.

JOURNAL OF HEPATOLOGY (2015)

Review Medicine, Research & Experimental

Targeting the Gut-Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers

Bjorn S. Madsen et al.

ADVANCES IN THERAPY (2013)

Article Biotechnology & Applied Microbiology

Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform

James J. Kozich et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2013)

Editorial Material Medicine, General & Internal

Liver disease in the UK: a Lancet Commission

Roger Williams et al.

LANCET (2013)

Article Gastroenterology & Hepatology

Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies

Joe West et al.

GASTROENTEROLOGY (2010)

Editorial Material Gastroenterology & Hepatology

Alcoholic Liver Disease: The Buzz May Be Gone, but the Hangover Remains

Vijay H. Shah

HEPATOLOGY (2010)

Article Medicine, General & Internal

Rifaximin Treatment in Hepatic Encephalopathy

Nathan M. Bass et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Biochemistry & Molecular Biology

TLR4 enhances TGF-β signaling and hepatic fibrosis

Ekihiro Seki et al.

NATURE MEDICINE (2007)

Article Substance Abuse

II. Veterans affairs cooperative study of polyenylphosphatidylcholine in alcoholic liver disease

CS Lieber et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2003)